Intrinsiqq
Surgical Science Sweden AB logo

Surgical Science Sweden AB Intrinsic Value

SUS.XSTO

Compare

Choose a model

Each card values Surgical Science Sweden AB a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

Surgical Science Sweden AB on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.

Years to project

Growth of earnings per share

Earnings per share; starts at its own recent growth

Exit P/E

Starts at the average of its 5-year median P/E, today's and a mature 18

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's earnings per share

    Diluted, last twelve months, as filed

    kr 1.83

  2. Earnings in 2031

    Grows 0.5% a year for 5 years

    kr 1.88

  3. Price in 2031

    kr 1.88 × 30.0 P/E

    kr 56.29

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    kr 34.95

  5. Fair value

    The most you can pay and still earn 10% a year

    kr 34.95

  6. Buy below

    Fair value minus your 25% margin of safety

    kr 26.21

Paying kr 59.05 instead gives -1.0% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

kr 34.95

Expected return

-1.0% a year

Future price, 2031

kr 56.29

Buy below

kr 26.21

Price 69% above fair valuePrice kr 59.05, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

Surgical Science Sweden AB (SUS.XSTO) intrinsic value and fair value

The calculator grows one of Surgical Science Sweden AB's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for SUS.XSTO; this is analysis, not investment advice.

Frequently asked

What is Surgical Science Sweden AB's (SUS.XSTO) intrinsic value?+

With Intrinsiqq's starting inputs, Surgical Science Sweden AB's fair value is about kr 34.95 a share, based on its earnings per share. That assumes earnings per share of kr 1.83 grows about 0.5% a year for 5 years, the stock then trades at 30.0 times earnings, and you want a 10.0% yearly return. On its other figures: free cash flow kr 36.75, revenue kr 272.45. Every input can be changed on the page; the result is a model, not a forecast.

Is Surgical Science Sweden AB overvalued?+

At kr 59.05, the price is 69% above that fair value of kr 34.95, and buying at today's price would return about -1.0% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from company filings, not investment advice.

What growth does the Surgical Science Sweden AB valuation assume?+

Earnings per share grows about 0.5% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at a default.

What is a good margin of safety for Surgical Science Sweden AB?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at kr 26.21. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Peers

Health Information Services · Pick stocks to compare with SUS.XSTO

CompareIntrinsic value
XVIVO.XSTOXVIVO Perfusion AB
kr 198.20-0.65%44
BONEX.XSTOBonesupport Holding AB
kr 320.40-1.90%78
CEVI.XSTOCellaVision AB
€17.84+0.34%54
STIL.XSTOStille AB
€21.95-2.88%61
BICO.XSTOBICO Group AB
€2.21+0.68%20
VIMIAN.XSTOVimian Group AB
€3.77-0.66%57
EQL.XSTOEql Pharma AB
€2.27-1.30%18
CARA.XSTOCarasent AB
€2.22-2.84%54

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SUS.XSTO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.